201 related articles for article (PubMed ID: 24390815)
1. (E)-2,4-Bis(p-hydroxyphenyl)-2-butenal enhanced TRAIL-induced apoptosis in ovarian cancer cells through downregulation of NF-κB/STAT3 pathway.
Cho SH; Park MH; Lee HP; Back MK; Sung HC; Chang HW; Kim JH; Jeong HS; Han SB; Hong JT
Arch Pharm Res; 2014 May; 37(5):652-61. PubMed ID: 24390815
[TBL] [Abstract][Full Text] [Related]
2. (E)-2,4-Bis(p-hydroxyphenyl)-2-butenal inhibits tumor growth via suppression of NF-κB and induction of death receptor 6.
Ban JO; Jung YS; Kim DH; Park KR; Yun HM; Lee NJ; Lee HP; Shim JH; Jeong HS; Lee YH; Ham YW; Han SB; Hong JT
Apoptosis; 2014 Jan; 19(1):165-78. PubMed ID: 24052407
[TBL] [Abstract][Full Text] [Related]
3. (E)-2,4-bis(p-hydroxyphenyl)-2-butenal has an antiproliferative effect on NSCLC cells induced by p38 MAPK-mediated suppression of NF-κB and up-regulation of TNFRSF10B (DR5).
Kollipara PS; Jeong HS; Han SB; Hong JT
Br J Pharmacol; 2013 Mar; 168(6):1471-84. PubMed ID: 23082969
[TBL] [Abstract][Full Text] [Related]
4. Cell growth inhibition and induction of apoptosis by snake venom toxin in ovarian cancer cell via inactivation of nuclear factor κB and signal transducer and activator of transcription 3.
Song JK; Jo MR; Park MH; Song HS; An BJ; Song MJ; Han SB; Hong JT
Arch Pharm Res; 2012 May; 35(5):867-76. PubMed ID: 22644854
[TBL] [Abstract][Full Text] [Related]
5. 2,4-bis (p-hydroxyphenyl)-2-butenal (HPB242) induces apoptosis via modulating E7 expression and inhibition of PI3K/Akt pathway in SiHa human cervical cancer cells.
Kim MS; Kim JH; Bak Y; Park YS; Lee DH; Kang JW; Shim JH; Jeong HS; Hong JT; Yoon DY
Nutr Cancer; 2012; 64(8):1236-44. PubMed ID: 23163851
[TBL] [Abstract][Full Text] [Related]
6. Anti-arthritis effects of (E)-2,4-bis(p-hydroxyphenyl)-2-butenal are mediated by inhibition of the STAT3 pathway.
Ban JO; Kim DH; Lee HP; Hwang CJ; Shim JH; Kim DJ; Kim TM; Jeong HS; Nah SS; Chen H; Dong Z; Ham YW; Kim Y; Han SB; Hong JT
Br J Pharmacol; 2014 Jun; 171(11):2900-12. PubMed ID: 24520814
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of a tyrosine-fructose Maillard reaction product, 2,4-bis(p-hydroxyphenyl)-2-butenal on amyloid-β generation and inflammatory reactions via inhibition of NF-κB and STAT3 activation in cultured astrocytes and microglial BV-2 cells.
Lee YJ; Choi DY; Choi IS; Han JY; Jeong HS; Han SB; Oh KW; Hong JT
J Neuroinflammation; 2011 Oct; 8():132. PubMed ID: 21982455
[TBL] [Abstract][Full Text] [Related]
8. Pro-survival effects by NF-κB, Akt and ERK(1/2) and anti-apoptosis actions by Six1 disrupt apoptotic functions of TRAIL-Dr4/5 pathway in ovarian cancer.
Yang J; Li G; Zhang K
Biomed Pharmacother; 2016 Dec; 84():1078-1087. PubMed ID: 27780136
[TBL] [Abstract][Full Text] [Related]
9. (E)-4-(3-(3,5-dimethoxyphenyl)allyl)-2-methoxyphenol inhibits growth of colon tumors in mice.
Zheng J; Park MH; Son DJ; Choi MG; Choi JS; Nam KT; Kim HD; Rodriguez K; Gann B; Ham YW; Han SB; Hong JT
Oncotarget; 2015 Dec; 6(39):41929-43. PubMed ID: 26474284
[TBL] [Abstract][Full Text] [Related]
10. (E)-2-methoxy-4-(3-(4-methoxyphenyl)prop-1-en-1-yl)phenol suppresses ovarian cancer cell growth via inhibition of ERK and STAT3.
Zheng J; Son DJ; Lee HL; Lee HP; Kim TH; Joo JH; Ham YW; Kim WJ; Jung JK; Han SB; Hong JT
Mol Carcinog; 2017 Sep; 56(9):2003-2013. PubMed ID: 28277616
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Par-4 sensitizes TRAIL-induced apoptosis via inactivation of NF-kappaB and Akt signaling pathways in renal cancer cells.
Lee TJ; Jang JH; Noh HJ; Park EJ; Choi KS; Kwon TK
J Cell Biochem; 2010 Apr; 109(5):885-95. PubMed ID: 20127709
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of a 2,4-bis(4-hydroxyphenyl)-2-butenal diacetate on neuro-inflammatory reactions via inhibition of STAT1 and STAT3 activation in cultured astrocytes and microglial BV-2 cells.
Kim JA; Yun HM; Jin P; Lee HP; Han JY; Udumula V; Moon DC; Han SB; Oh KW; Ham YW; Jung HS; Song HS; Hong JT
Neuropharmacology; 2014 Apr; 79():476-87. PubMed ID: 23891616
[TBL] [Abstract][Full Text] [Related]
13. PDCD6 additively cooperates with anti-cancer drugs through activation of NF-κB pathways.
Park SH; Lee JH; Lee GB; Byun HJ; Kim BR; Park CY; Kim HB; Rho SB
Cell Signal; 2012 Mar; 24(3):726-33. PubMed ID: 22142513
[TBL] [Abstract][Full Text] [Related]
14. Caspase-mediated p65 cleavage promotes TRAIL-induced apoptosis.
Kim HS; Chang I; Kim JY; Choi KH; Lee MS
Cancer Res; 2005 Jul; 65(14):6111-9. PubMed ID: 16024612
[TBL] [Abstract][Full Text] [Related]
15. Artesunate enhances TRAIL-induced apoptosis in human cervical carcinoma cells through inhibition of the NF-κB and PI3K/Akt signaling pathways.
Thanaketpaisarn O; Waiwut P; Sakurai H; Saiki I
Int J Oncol; 2011 Jul; 39(1):279-85. PubMed ID: 21537836
[TBL] [Abstract][Full Text] [Related]
16. Janus activated kinase 2/signal transducer and activator of transcription 3 pathway mediates icariside II-induced apoptosis in U266 multiple myeloma cells.
Kim SH; Ahn KS; Jeong SJ; Kwon TR; Jung JH; Yun SM; Han I; Lee SG; Kim DK; Kang M; Chen CY; Lee JW; Kim SH
Eur J Pharmacol; 2011 Mar; 654(1):10-6. PubMed ID: 21172343
[TBL] [Abstract][Full Text] [Related]
17. Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3.
Chen KF; Chen HL; Liu CY; Tai WT; Ichikawa K; Chen PJ; Cheng AL
Biochem Pharmacol; 2012 Mar; 83(6):769-77. PubMed ID: 22230479
[TBL] [Abstract][Full Text] [Related]
18. Curcumin enhances Apo2L/TRAIL-induced apoptosis in chemoresistant ovarian cancer cells.
Wahl H; Tan L; Griffith K; Choi M; Liu JR
Gynecol Oncol; 2007 Apr; 105(1):104-12. PubMed ID: 17174384
[TBL] [Abstract][Full Text] [Related]
19. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.
Cuello M; Ettenberg SA; Nau MM; Lipkowitz S
Gynecol Oncol; 2001 Jun; 81(3):380-90. PubMed ID: 11371126
[TBL] [Abstract][Full Text] [Related]
20. Ethanolic extract of Brazilian green propolis sensitizes prostate cancer cells to TRAIL-induced apoptosis.
Szliszka E; Zydowicz G; Janoszka B; Dobosz C; Kowalczyk-Ziomek G; Krol W
Int J Oncol; 2011 Apr; 38(4):941-53. PubMed ID: 21286663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
